Skip to main content

Oramed Pharmaceuticals Inc.

ORMP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001176309

In the last 90 days, Oramed Pharmaceuticals Inc. insiders filed 0 open-market purchases and 2 sales; 84 institutions reported holding it in 13F filings for Q2 2026, worth $80.7M in total; no superinvestor holds it.

Politicians who traded ORMP

Since 2020, newest trade first. Shares and options by default, including trades reported under an earlier ticker.

Trades
4
Filings
4
Politicians
2
Buys / sells
1 / 3
Estimated volume
$56.5K
Sum of range midpoints
Politicians who traded ORMP
PoliticianTradesBuys / sellsEst. volumeLast tradedLast filed
Brad Knott House · NC
10 / 1$32.5KJan 10, 2025Feb 25, 2025
31 / 2$24.0KJan 14, 2022Jan 14, 2022

Trades

Reported trades in Oramed Pharmaceuticals Inc., newest filings first.

Politician trades
PoliticianAssetTypeOwnerTradedFiledDelayAmountSource
Brad Knott House · NC
ORMPOramed Pharmaceuticals Inc. - Common StockSellSelfJan 10, 2025Feb 25, 202546 daysLate$15K-$50KFiling
ORMPOramed Pharmaceuticals Inc.SellSelfJan 14, 2022Jan 14, 2022Same day$1K-$15KFiling
ORMPOramed Pharmaceuticals Inc.Sell (partial)SelfOct 1, 2021Nov 3, 202133 days$1K-$15KFiling
ORMPOramed Pharmaceuticals Inc.BuySelfApr 23, 2021May 24, 202131 days$1K-$15KFiling

Source: U.S. House Clerk and Senate Office of Public Records (eFD). Amounts are the ranges filers report. Profiles, committees and photos: the unitedstates project (public domain). District maps: U.S. Census Bureau.